Next |
home / stock / vvos / vvos message board
Subject | By | Source | When |
---|---|---|---|
Goes to a dollar in pre market, loses | PennyPusher786 | investorshub | 03/02/2023 3:23:11 PM |
Lol closes Red... weak ass CEOs out here | PennyPusher786 | investorshub | 03/01/2023 6:35:10 PM |
Junk | harry crumb | investorshub | 03/01/2023 4:29:12 PM |
Loadin .60 | OffTheGrid | investorshub | 03/01/2023 3:38:33 PM |
Shorts want shares badly, Schwab contacted me again | zdog | investorshub | 01/11/2023 10:46:26 PM |
I was just contacted by Schwab asking me | zdog | investorshub | 01/06/2023 10:25:29 PM |
nice job it dropped to 1.47 smh | TheFinalCD | investorshub | 01/06/2023 6:13:22 PM |
I got out shortly after this dropped below $2.80 | Pedro2004 | investorshub | 01/06/2023 3:11:24 PM |
znewcar1: $VVOS hod2.15 does it BO2.96 YH? 2.32 should be critical. | znewcar1 | investorshangout | 01/05/2023 8:39:57 PM |
#$VVOS ?? another BIO play that ran big! | da_stock_analyst | investorshub | 01/05/2023 12:20:13 AM |
znewcar1: $VVOS 154% v112,3M c1.88 f23,012M H2.96 GapChopNgo | znewcar1 | investorshangout | 01/04/2023 9:02:17 PM |
Sold 27k 3.20-3.330 I owe my friend | TechandBio | investorshub | 01/04/2023 8:19:38 PM |
wow 400k on ask @ 2.20 | TheFinalCD | investorshub | 01/04/2023 5:09:40 PM |
CONGRAT$ NOW 2.35 AND HALTED DOWN | TheFinalCD | investorshub | 01/04/2023 4:03:41 PM |
The Insider Dumping at $2.80's range is getting | Pedro2004 | investorshub | 01/04/2023 3:48:55 PM |
Good one !!! out all rest 2.93 | tw0122 | investorshub | 01/04/2023 3:37:18 PM |
ALL OUT 2.90 | TheFinalCD | investorshub | 01/04/2023 3:28:50 PM |
znewcar1: $VVOS hod2.93 | znewcar1 | investorshangout | 01/04/2023 3:28:13 PM |
$VVOS: ALMOST THREE ....... cmonnnnnnnn do it | makinezmoney | investorshub | 01/04/2023 3:27:58 PM |
$VVOS HALTED UP AGAIN I STILL HAVE SHARES | TheFinalCD | investorshub | 01/04/2023 3:22:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...
Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million...
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...